Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer.
about
Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic diseaseBRCA1 mRNA levels following a 4-6-week intervention with oral 3,3'-diindolylmethaneWorse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis.Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece."Why take it if you don't have anything?" breast cancer risk perceptions and prevention choices at a public hospitalSecond malignancies after breast cancer: the impact of different treatment modalitiesGenetic counselors: translating genomic science into clinical practiceEthical issues related to BRCA gene testing in orthodox Jewish women.Molecular genetics analysis of hereditary breast and ovarian cancer patients in India.Risk perception and cancer worries in families at increased risk of familial breast/ovarian cancer.Diet and predictors of dietary intakes in women with family history of breast and/or ovarian cancer.
P2860
Q24675652-DDC1E400-E22B-43A5-A6E5-0E80E01FD168Q34283643-AD59E47B-E7E6-4765-8464-9500FA195740Q35224593-ECDDAEE4-9C79-45A6-9F42-C7C96074BB9FQ35619211-3FDB8838-7463-4F35-84FA-892D2C742197Q35901573-6E89DAB9-90A5-4AD8-BB31-A3784EE63DC4Q36494170-17D500EE-66DA-4D39-8DF7-F501CD94A1A8Q36524819-369B6836-3552-49B7-9CC2-816971261F35Q37178691-0B85EB5C-99F3-4CAA-83FF-B23D5D0938D1Q37316299-7DEEA93F-B8AD-4969-9426-97D129AC8B8FQ37626759-91E18DFD-ADE9-4C77-9661-9A43ED87F76AQ55115973-CB791DA7-926E-4059-B4A2-0D6FE610A3C9
P2860
Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clinical considerations in the ...... ary breast and ovarian cancer.
@ast
Clinical considerations in the ...... ary breast and ovarian cancer.
@en
type
label
Clinical considerations in the ...... ary breast and ovarian cancer.
@ast
Clinical considerations in the ...... ary breast and ovarian cancer.
@en
prefLabel
Clinical considerations in the ...... ary breast and ovarian cancer.
@ast
Clinical considerations in the ...... ary breast and ovarian cancer.
@en
P2860
P1433
P1476
Clinical considerations in the ...... tary breast and ovarian cancer
@en
P2093
Mark E Robson
P2860
P304
P356
10.1177/107327480200900602
P50
P577
2002-11-01T00:00:00Z